Comparison of Pharmacokinetics of Tenofovir Alafenamide (TAF) With Tenofovir Disoproxil (TDF) in Pregnant and Postpartum Women and Their Infants in PrEP-PP Study
Latest Information Update: 06 Sep 2024
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms PrEP-PP PK
- 28 Nov 2023 Status changed from active, no longer recruiting to completed.
- 08 May 2023 Status changed from recruiting to active, no longer recruiting.
- 01 Nov 2022 Status changed from not yet recruiting to recruiting.